S-1/A: Beneficient Files Amendment No. 3 to Form S-1, Registers 203 Million Shares for Potential Resale
Securities Registration (Form S-1 Amendment)
Beneficient files an amendment to its registration statement to register the potential resale of over 203 million shares of Class A common stock by selling holders.
Summary
- Beneficient has filed Amendment No. 3 to its Form S-1 registration statement.
- The filing registers 203,212,927 shares of Class A common stock for potential resale by selling holders.
- These shares include SEPA shares, Conversion Shares, Warrant Shares, Mendoza shares, Interest Solutions shares, Convergency Partners shares, Maxim Shares and Vendor Shares.
- The company may issue and sell up to $250 million of Class A common stock to Yorkville under a Standby Equity Purchase Agreement (SEPA).
- Approximately $3.9 million has already been received from Yorkville under the SEPA.
- The company also entered into a Purchase Agreement with Yorkville for Convertible Debentures up to $4.0 million, convertible into Class A common stock.
- The company will issue warrants to Yorkville to purchase up to 1,325,382 shares of Class A common stock at an exercise price of $2.63.
- The company will not receive any proceeds from the sale of shares by the Selling Holders.
- The company received stockholder approval to increase the number of authorized shares of Class A common stock from 18,750,000 to 5,000,000,000.
- As of November 8, 2024, the company had 4,841,350 shares of Class A common stock outstanding.
- The company may issue up to approximately 203,978,450 shares of Class A common stock under Pricing Option 1 and up to approximately 199,772,709 shares of Class A common stock under Pricing Option 2.
- The company may not have access to the full $246.1 million amount remaining available under the SEPA due to the reasons noted above.
Sentiment
Score: 5
Explanation: The document is neutral in sentiment, primarily focused on outlining the details of a securities registration and potential future transactions. It does not express strong positive or negative views.
Risks
- Future resales of Class A common stock may cause the market price of Class A common stock to drop significantly.
- The company may not have access to the full $246.1 million amount remaining available under the SEPA due to the reasons noted above.
Future Outlook
The document outlines the potential for future sales of Class A common stock under the SEPA and Convertible Debentures, but the actual timing and amounts are uncertain.
Industry Context
The document relates to the financial transactions of a company in the alternative asset management space, which is a growing but complex and illiquid market.
Stakeholder Impact
- Existing shareholders may experience dilution due to the potential issuance of new shares.
- The market price of the company's stock could be influenced by future sales of Class A common stock.
Next Steps
- The selling holders may offer and sell the offered securities from time to time.
- The company may elect to issue and sell shares of Class A common stock to Yorkville under the SEPA.
- Yorkville will purchase and the Company will issue an additional $2.0 million in aggregate principal amount of Convertible Debentures on or before the first business day after the date the registration statement of which this prospectus forms a part registering the resale of the Conversion Shares and the Warrant Shares is declared effective by the Securities and Exchange Commission.
Key Dates
| Date | Description |
|---|---|
| 2023-06-27 | Date of Standby Equity Purchase Agreement (SEPA) between Beneficient and Yorkville. |
| 2024-08-06 | Date of Securities Purchase Agreement between Beneficient and Yorkville. |
| 2025-02-06 | Maturity Date of the Convertible Debentures. |
| 2027-08-06 | Expiration date of the Warrants. |
Keywords
Class A common stock, registration statement, securities, Yorkville, SEPA, Beneficient
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.